Cleared Traditional

GRAHAM-FIELD ULTRASOUND SCANNING GEL (K944597) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K944597 · Chester Labs, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1995
Decision
275d
Days
Class 2
Risk

K944597 is an FDA 510(k) clearance for the GRAHAM-FIELD ULTRASOUND SCANNING GEL. Classified as System, Imaging, Pulsed Echo, Ultrasonic (product code IYO), Class II - Special Controls.

Submitted by Chester Labs, Inc. (Erlanger, US). The FDA issued a Cleared decision on June 21, 1995 after a review of 275 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1560 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Chester Labs, Inc. devices

Submission Details

510(k) Number K944597 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 19, 1994
Decision Date June 21, 1995
Days to Decision 275 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
168d slower than avg
Panel avg: 107d · This submission: 275d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IYO System, Imaging, Pulsed Echo, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYO System, Imaging, Pulsed Echo, Ultrasonic

All 204
Devices cleared under the same product code (IYO) and FDA review panel - the closest regulatory comparables to K944597.
RT55 DIAGNOSTIC ULTRASOUND SYSTEM
K953752 · General Electric Co. · Mar 1996
SONOS IMAGING SYSTEM (2000/2500 & 1000/1500)
K952540 · Hewlett-Packard Co. · Mar 1996
SIEMENS SONOLINE 4XX
K946179 · Siemens Medical Solutions USA, Inc. · Oct 1995
PVK-357AT
K943303 · Toshiba America Medical Systems, In.C · Feb 1995
HP 77010CF
K943634 · Hewlett-Packard Co. · Sep 1994
CAPASEE
K933747 · Toshiba America Medical Systems, In.C · May 1994